Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study
Pamela Minicozzi(Fondazione IRCCS Istituto Nazionale dei Tumori), Karri Seppä, Gemma Gatta(Fondazione IRCCS Istituto Nazionale dei Tumori), Ladislav Dušek(Institute of Health Information and Statistics), Zoé Uhry(Lyon 1 Université), Nadya Dimitrova(Istituto Superiore di Sanità), Margit Mägi(Universidad de Granada), Guido Mazzoleni, Alice Nennecke, Andrea Eberle(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Jean Faivre(Institut de Cancérologie de Lorraine), Mario Šekerija(London Cancer), Silvia Rossi(University of Parma), Laura Botta(Fondazione IRCCS Istituto Nazionale dei Tumori), Stefano Ferretti(University of Ferrara), G. Schubert-Fritschle(Ludwig-Maximilians-Universität München), Bernd Holleczek(Krebsregister Saarland), Annalisa Trama(Fondazione IRCCS Istituto Nazionale dei Tumori), A Barchielli, Otto Visser(Netherlands Comprehensive Cancer Organisation), K. Henau, A. Bulatko, Alexander Katalinic(Independent Centre for Privacy Protection), Rafael Marcos‐Gragera(Generalitat de Catalunya), Nadine Bossard(Istituto Superiore di Sanità), Milena Sant(Fondazione IRCCS Istituto Nazionale dei Tumori), Tiiu Aareleid(Fondazione IRCCS Istituto Nazionale dei Tumori), Hermann Brenner(Universidad de Granada), Marc Colonna(Universidad de Granada), Anne‐Marie Bouvier(Inserm), Z. Valerianova(Istituto Superiore di Sanità), Nea Malila(Istituto Superiore di Sanità), Kaire Innos(National Institute for Health Development), Adele Caldarella, Miroslav Zvolský(Institute of Health Information and Statistics), María‐José Sánchez(Instituto de Investigación Biosanitaria de Granada), Andrea Tavilla, Paul M. Walsh(National Cancer Registry), Monika Hackl(Universidad de Granada), Jan Heidrich(Universidad de Granada), Roland Stabenow(Fondazione IRCCS Istituto Nazionale dei Tumori), Adriano Giacomin, Sabine Luttmann(Fondazione IRCCS Istituto Nazionale dei Tumori), E. Van Eycken(Istituto Superiore di Sanità), Jutta Engel(Universidad de Granada), K.M. Clough-Gorr, N. Zielonke(Istituto Superiore di Sanità), Carlotta Buzzoni(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 45
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
|The Lancet|2017|2.1k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k